Overview

Pramipexole for Binge Eating Disorder

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the effects that the drug pramipexole has on mood, food craving, and other behaviors that may be related to binge eating disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Neuropsychiatric Research Institute, Fargo, North Dakota
Treatments:
Pramipexole